Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients

被引：0
作者：
Lívia Rojkó
Lilla Reiniger
Vanda Téglási
Katalin Fábián
Orsolya Pipek
Attila Vágvölgyi
László Agócs
János Fillinger
Zita Kajdácsi
József Tímár
Balázs Döme
Zoltán Szállási
Judit Moldvay
机构：
[1] National Korányi Institute of Pulmonology,VI. Department of Pulmonology
[2] Semmelweis University,1st Department of Pathology and Experimental Cancer Research
[3] Semmelweis University,MTA
[4] Semmelweis University,SE NAP, Brain Metastasis Research Group, 2nd Department of Pathology, Hungarian Academy of Sciences
[5] Szent Imre Teaching Hospital,Department of Pulmonology
[6] Eötvös Loránd University,Department of Pathology
[7] National Korányi Institute of Pulmonology,Department of Physics of Complex Systems
[8] National Institute of Oncology-Semmelweis University,Department of Thoracic Surgery
[9] National Korányi Institute of Pulmonology,Department of Thoracic Surgery
[10] National Institute of Oncology,Department of Pathology
[11] Semmelweis University,Department of Pathology
[12] National Korányi Institute of Pulmonology-Semmelweis University,2nd Department of Pathology
[13] Medical University of Vienna,Department of Tumor Biology
[14] Harvard Medical School,Comprehensive Cancer Center, Division of Thoracic Surgery
[15] Technical University of Denmark,Children’s Hospital Informatics Program at the Harvard–Massachusetts Institute of Technology, Division of Health Sciences and Technology
来源：
Journal of Cancer Research and Clinical Oncology | 2018年 / 144卷
关键词：
PD-L1; PD-1; Immunohistochemistry; Lung cancer; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1219 / 1226
页数：7
相关论文
共 206 条
[1]  
Chacon JA(2016)The impact of chemotherapy, radiation and epigenetic modifiers in cancer cell expression of immune inhibitory and stimulatory molecules and anti-tumor efficacy Vaccines 4 43-1671
[2]  
Schutsky K(2016)The international epidemiology of lung cancer: latest trends, disparities J Thorac Oncol 11 1653-1554
[3]  
Powell DJ(2017)The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines Oncol Rep 37 1545-301
[4]  
Cheng TY(2010)Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule Breast Cancer Res BCR 12 R48-90131
[5]  
Cramb SM(2004)Correlation of different markers (p53, EGF-R, c-erbB-2, Ki-67) expression in the diagnostic biopsies and the corresponding resected tumors in non-small cell lung cancer Lung Cancer (Amsterdam Netherlands) 44 295-1833
[6]  
Baade PD(2017)PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability Oncotarget 8 90123-8010
[7]  
Youlden DR(2016)PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis Oncotarget 7 19738-103
[8]  
Nwogu C(2015)Chemotherapy induces programmed cell death-ligand 1 overexpression via the nuclear factor-kappaB to foster an immunosuppressive tumor microenvironment in ovarian cancer Cancer Res 75 5034-1571
[9]  
Reid ME(2016)Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer New Engl J Med 375 1823-undefined
[10]  
Characteristics T(2016)Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer Sci Rep 6 20090-undefined
12345678910